@misc{indiciae2831ec008674,
  title = {Targeting IL-2 to inflamed tissues via oxidation-specific epitopes enables third-generation bispecific IL-2 therapeutics},
  author = {Vazquez, T. and Cuevas-martinez, M. and Billiald, N. and Porsch, F. and Sadddouk, F.-Z. and Sion, M. and Laurens, L. and Albalaa, C. and Zentilin, L. and Peil, L. and Teyra, J. and Bouceba, T. and Leleu, I. and Pied, S. and Ustav, M. and Tedgui, A. and Zacchigna, S. and Le Grand, R. and Rosenzwajg, M. and Mallat, Z. and Binder, C. J. and Klatzmann, D.},
  year = {2026},
  doi = {10.64898/2026.09.10.750022},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.10.750022v1},
  note = {Source identifier: 10.64898/2026.09.10.750022}
}